title: Increased sensitivity of electrophysiological study by isoproterenol infusion in unexplained syncope.
abstract: The purpose of the study was to evaluate the interests of electrophysiologic study (EPS) after infusion of isoproterenol in patients with syncope and negative EPS in control state.
  
  
  METHODS
  1350 patients were consecutively admitted for syncope and EPS. Patients were included if they had no history of tachycardia, a normal Holter monitoring, a negative EPS in control state. EPS was repeated after infusion of 2-4 mug/kg of isoproterenol.
  
  
  RESULTS
  256 patients, 35 with exercise-related syncope and 105 with heart disease (HD), were recruited. After isoproterenol, an arrhythmia was identified as the sign associated with syncope in 102 patients (40%): SVT in 32 patients, VT in 36 patients, infrahisian 2nd or 3rd degree AV block in three patients and vasovagal reaction in 31 patients. Arrhythmias were more frequent in patients with HD (50/105) than in those without HD (52/151) (p<0.05); SVT tended to be more frequent in patients without HD (n=23) than in those with HD (n=9) (p<0.1); VT was more frequent in patients with HD (n=26) than in those without HD (n=10) (p<0.001). There was no relationship between a positive isoproterenol testing and occurrence of syncope at exercise (19/35 vs 81/221) (p<0.1).
  
  
  CONCLUSIONS
  isoproterenol infusion increased the sensitivity of EPS in patients with syncope, related or not to exercise, and with negative study in control state, but principally in those with HD. However, SVT was diagnosed in patients without HD and EPS associated with isoproterenol infusion remained an important and rapid tool to establish this diagnosis.
authors.affiliation: CHU de Brabois, Cardiologie, 54500 Vandoeuvre Les Nancy, France. b.brembilla-perrot@chu-nancy.fr
authors.forename: Beatrice
authors.initials: B
authors.lastname: Brembilla-Perrot
authors.forename: Iyad
authors.initials: I
authors.lastname: Muhanna
authors.forename: Olivier
authors.initials: O
authors.lastname: Marçon
authors.forename: Batric
authors.initials: B
authors.lastname: Popovic
authors.forename: Arnaud
authors.initials: A
authors.lastname: Terrier de la Chaise
authors.forename: Pierre
authors.initials: P
authors.lastname: Louis
authors.forename: Marius
authors.initials: M
authors.lastname: Andronache
authors.forename: Marc
authors.initials: M
authors.lastname: Nippert
authors.forename: Olivier
authors.initials: O
authors.lastname: Claudon
authors.forename: Daniel
authors.initials: D
authors.lastname: Beurrier
authors.forename: Pierre
authors.initials: P
authors.lastname: Houriez
authors.forename: Hadj
authors.initials: H
authors.lastname: Belhakem
mesh_terms: D002316:Cardiotonic Agents; D022062:Electrophysiologic Techniques, Cardiac; D005260:Female; D006801:Humans; D007545:Isoproterenol; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D013575:Syncope / Q000175:diagnosis* / Q000503:physiopathology
chemical_list: D002316:Cardiotonic Agents; D007545:Isoproterenol